Latest Articles

Publication Date
NHS GP issues 'not normal' reminder to women who get periods - Essex Live

NHS GP issues 'not normal' reminder to women who get periods Essex Live

Published: Feb. 12, 2026, 7:11 p.m.
Dr Charity Binka urges bold action on sexual and reproductive health - MyJoyOnline

Dr Charity Binka urges bold action on sexual and reproductive health MyJoyOnline

Published: Feb. 12, 2026, 3:37 p.m.
Lovers sale: 30% off sex toys plus a free Womanizer vibrator - Mashable

Lovers sale: 30% off sex toys plus a free Womanizer vibrator Mashable

Published: Feb. 12, 2026, 10 a.m.
Best sex toy deal: LELO added a new toy to its ENIGMA lineup - Mashable

Best sex toy deal: LELO added a new toy to its ENIGMA lineup Mashable

Published: Feb. 12, 2026, 10 a.m.
Lovehoney's sex toy Advent calendars: 24 days of fun, $302 off - Mashable

Lovehoney's sex toy Advent calendars: 24 days of fun, $302 off Mashable

Published: Feb. 12, 2026, 10 a.m.
The cost of Ontario’s healthcare gaps on students’ sexual health - The Eyeopener

The cost of Ontario’s healthcare gaps on students’ sexual health The Eyeopener

Published: Feb. 10, 2026, 9:26 p.m.
The cost of Ontario’s healthcare gaps on students’ sexual health - theeyeopener.com

The cost of Ontario’s healthcare gaps on students’ sexual health theeyeopener.com

Published: Feb. 10, 2026, 9:26 p.m.
Nanotechnology for reproductive healthcare: a comprehensive review.

The advancement of nanotechnology has revolutionized reproductive healthcare worldwide. It has enabled the treatment of various conditions, such as infertility, endometriosis, ectopic pregnancies, erectile dysfunction, sexually transmitted infections (STIs), and …

Published: Feb. 9, 2026, midnight
Valentine's Day sex toy deals are already heating up. Save up to 85% on famous toys. - Mashable

Valentine's Day sex toy deals are already heating up. Save up to 85% on famous toys. Mashable

Published: Feb. 6, 2026, 10:51 p.m.
Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation Study.

LY01021 is a novel oral small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of various sex hormone-dependent disorders. This study aimed to evaluate the safety, tolerability, pharmacokinetics (PK), …

Published: Feb. 5, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!